The hinge region of the human papillomavirus type 8 E2 protein activates the human p21WAF1/CIP1 promoter via interaction with Sp1

References

1. Arnosti D. N., Merino A., Reinberg D., Schaffner W. 1993; Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription. EMBO Journal 12:157–166
   [Google Scholar]
2. Benson J. D., Lawande R., Howley P. M. 1997; Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins. Journal of Virology 71:8041–8047
   [Google Scholar]
3. Boeckle S., Pfister H., Steger G. 2002; A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2. Virology (in Press)
   [Google Scholar]
4. Breiding D. E., Sverdrup F., Grossel M., Moscufo N., Boonchai W., Androphy E. J. 1997; Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Molecular and Cellular Biology 17:7208–7219
   [Google Scholar]
5. Dotto G. P. 2000; p21^WAF1/Cip1: more than a break to the cell cycle?. Biochimica et Biophysica Acta 1471:M43–M56
   [Google Scholar]
6. Enzenauer C., Mengus G., Lavigne A.-C., Davidson I., Pfister H., May M. 1998; Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 41:80–90
   [Google Scholar]
7. Giri I., Yaniv M. 1988; Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveal three distinct functional domains. EMBO Journal 7:2823–2829
   [Google Scholar]
8. Haller K., Stubenrauch F., Pfister H. 1995; Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214:245–255
   [Google Scholar]
9. Ham J., Dostatni N., Arnos F., Yaniv M. 1991; Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein. EMBO Journal 10:2931–2940
   [Google Scholar]
10. Ham J., Steger G., Yaniv M. 1994; Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. EMBO Journal 13:147–157
    [Google Scholar]
11. Haugen T. H., Turek L., Mercurio F. M., Cripe T. P., Olson B. J., Anderson R. D., Seidl D., Karin M., Schiller J. 1988; Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO Journal 7:4245–4253
    [Google Scholar]
12. Heike T., Miyatake S., Yoshida M., Arai K. I., Naoka A. 1989; Bovine papilloma virus encoded E2 protein activates lymphokine genes through DNA elements distinct from the consensus motif, in the long control region of its own genome. EMBO Journal 8:1411–1417
    [Google Scholar]
13. Kardassis D., Papakosta P., Pardali K., Moustakas A. 1999; c-Jun transactivates the promoter of the human p21^WAF1/Cip1 gene by acting as a super activator of the ubiquitous transcription factor Sp1. Journal of Biological Chemistry 274:29572–29581
    [Google Scholar]
14. Lai M.-C., Teh B., Tarn W.-Y. 2000; A human papillomavirus E2 transcriptional activator. Journal of Biological Chemistry 274:11832–11841
    [Google Scholar]
15. Lambert P. F., Spalholz B. A., Howley P. M. 1987; A transcriptional repressor encoded by BPV1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 50:69–78
    [Google Scholar]
16. Lee D., Lee B., Kim J., Kim D. W., Choe J. 2000; cAMP response element binding protein-binding protein binds to human papillomavirus E2 protein and activates E2 dependent transcription. Journal of Biological Chemistry 275:7045–7051
    [Google Scholar]
17. Lehman C. W., King D. S., Botchan M. R. 1997; A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transformation but is defective in transformation and plasmid retention. Journal of Virology 71:3652–3665
    [Google Scholar]
18. Li R., Knight J., Bream G., Stenlund A., Botchan M. 1989; Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes and Development 3:510–526
    [Google Scholar]
19. Li R., Knight J. D., Jackson S. P., Tjian R., Botchan M. R. 1991; Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65:493–505
    [Google Scholar]
20. Liu J. S., Kuo S. R., Broker T., Chow L. T. 1995; The function of the human papillomavirus type 11 E1, E2 and E2C proteins in cell-free DNA replication. Journal of Biological Chemistry 270:27283–27291
    [Google Scholar]
21. McBride A. A., Bolen J. B., Howley P. M. 1989a; Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. Journal of Virology 63:5076–5085
    [Google Scholar]
22. McBride A. A., Byrne J. C., Howley P. M. 1989b; E2 polypeptides encoded by the bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proceedings of the National Academy of Sciences, USA 86:510–514
    [Google Scholar]
23. Miller Rank N., Lambert P. F. 1995; Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. Journal of Virology 69:6323–6334
    [Google Scholar]
24. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., Moustakas A. 2000; Role of Smad proteins and transcription factor Sp1 in p21^Waf1/Cip1 regulation by transforming growth factor-beta. Journal of Biological Chemistry 275:29244–29256
    [Google Scholar]
25. Peng Y.-C., Breiding D. E., Sverdrup F., Richard J., Androphy E. J. 2000; AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. Journal of Virology 74:5872–5879
    [Google Scholar]
26. Pernose K. J., McBride A. A. 2000; Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. Journal of Virology 74:6031–6038
    [Google Scholar]
27. Prowse D. M., Bolgan L., Molnar A., Dotto G. P. 1997; Involvement of the Sp3 transcription factor in induction of p21^Cip1/WAF1 in keratinocyte differentiation. Journal of Biological Chemistry 272:1308–1314
    [Google Scholar]
28. Purdie K. J., Sexton C. J., Proby C. M., Glover M. T., Williams A. T., Stables J. N., Leigh I. M. 1993; Malignant transformation of cutaneous lesions in renal allograft patients: a role of human papillomaviruses. Cancer Research 53:5328–5333
    [Google Scholar]
29. Spalholz B. A., Yang Y. C., Howley P. M. 1985; Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product. Cell 42:183–191
    [Google Scholar]
30. Spalholz B. A., Van de Pol S. B., Howley P. M. 1991; Characterization of the cis elements involved in basal and E2 transactivated expression of the bovine papillomavirus P₂₄₄₃ promoter. Journal of Virology 65:743–753
    [Google Scholar]
31. Steger G., Corbach S. 1997; Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. Journal of Virology 71:50–58
    [Google Scholar]
32. Steger G., Ham J., Lefebvre O., Yaniv M. 1995; The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO Journal 14:329–340
    [Google Scholar]
33. Stubenrauch F., Pfister H. 1994; Low-affinity E2 binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter. Journal of Virology 68:6959–6966
    [Google Scholar]
34. Stubenrauch F., Hummel M., Iftner T., Laimins L. A. 2000; The E8E2C protein, a negative regulator of viral transcription and replication, is required for chromosomal maintenance of human papillomavirus type 31 in keratinocytes. Journal of Virology 74:1178–1186
    [Google Scholar]
35. Ushikai M., Lace M. J., Yamakawa Y., Kono M., Anson J. and others 1994; trans activation by the full-length E2 protein of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. Journal of Virology 68:6655–6666
    [Google Scholar]
36. Xiao H., Hasegawa T., Isobe K. I. 2000; p300 collaborates with Sp1 and Sp3 in p21waf1/cip1 promoter activation induced by histone deacetylase inhibitor. Journal of Biological Chemistry 275:1371–1376
    [Google Scholar]
37. Yao J.-M., Breiding D. E., Androphy E. J. 1998; Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. Journal of Virology 72:1013–1019
    [Google Scholar]
38. Zou N., Lin B. Y., Duan F., Lee K.-Y., Jin G., Guan R., Yao G., Lefkowitz E. J., Broker T., Chow L. T. 2000; The hinge of human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. Journal of Virology 74:3761–3770
    [Google Scholar]